Medical/Pharmaceuticals
Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility
BEIJING, May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. High levels of DNA fragmentation, defined as a breakdown of genetic material inside sperm cells, ...
2026-05-10 17:00
4865
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
NEWARK, Del., May 9, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-based authorization model. This policy shift addresses the i...
2026-05-10 01:30
7155
South and East Asia identified as hotspots of global warming related impacts on male fertility
BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased ...
2026-05-09 15:01
6559
Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF
BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many c...
2026-05-09 09:00
5996
World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
SHANGHAI, May 8, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel antibody, has received clearance...
2026-05-09 08:00
7192
AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and...
2026-05-08 20:26
5874
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review ...
2026-05-08 19:29
6449
What Sets Medtec China Apart from Other Medical Device Manufacturing Expos
SHANGHAI, May 8, 2026 /PRNewswire/ -- Building a successful medical device
requires precise engineering, reliable materials, and a resilient supply chain.
Finding the right partners to bring your vision to life is a major challenge.
TheMedtec China trade show
2026-05-08 19:21
5313
The 23rd World Congress on Breast Cancer and Breast Healthcare to Be Held in Tianjin
TIANJIN, China, May 8, 2026 /PRNewswire/ -- To further promote academic exchange and practical collaboration in the global field of breast health, and to advance the standardized prevention and treatment of breast cancer, the 23rd World Congress on Breast Cancer and Breast Healthcare will be held...
2026-05-08 17:06
3751
Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 8, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today annou...
2026-05-08 17:02
5005
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, with trans-splicing ribozyme-based RNA editing platform SEOUL, South Korea, May 8, 2026 /PRNewswire/ -- Rznomics a biopharmaceutical company specializing in RNA-based gene ther...
2026-05-08 16:17
5121
Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87
HANGZHOU, China, May 7, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that the Center for Drug Evaluation of China's National Medical P...
2026-05-08 08:30
4901
VARON Highlights Wellness-Focused Mother's Day Gifts That Support Comfort and Independence
NEW YORK, May 7, 2026 /PRNewswire/ -- As families increasingly prioritize
meaningful and practical gifts for aging parents and loved ones, VARON
2026-05-08 00:10
5203
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
JAKARTA, Indonesia, May 7, 2026 /PRNewswire/ -- In conjunction with World Immunization Week, Pfizer Indonesia, together with healthcare professionals has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out simultaneously across Indo...
2026-05-07 23:05
4164
Fertility patients vulnerable to social media overload of misleading data where evidence and algorithms collide
BEIJING, May 7, 2026 /PRNewswire/ -- Patient information overload dominated by misleading social media and marketing is causing patients experiencing infertility to have unrealistic expectations about treatment success often resulting in psychological distress. "Never before have patients had ...
2026-05-07 14:53
4435
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation
CAMBRIDGE, Mass., May 6, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will be...
2026-05-07 11:29
5236
Move towards global consensus guidelines on surrogacy with mounting concerns over human rights violations
BEIJING, May 7, 2026 /PRNewswire/ -- World leaders in assisted reproductive technology are finalising global consensus guidelines on minimal standards in surrogacy to address mounting concerns about severe human rights violations. The standards will attempt to tackle inconsistent or inadequate ...
2026-05-07 09:00
3645
AID 2026 to Showcase Booming Opportunities in Silver Economy
SHANGHAI, May 7, 2026 /PRNewswire/ -- International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, Shanghai 2026 (hereinafter referred to as AID 2026), widely recognized as China's leading event for the senior care and silver economy sectors, will be held on June 4–6 at Shangh...
2026-05-07 09:00
3826
19.3% Weight Reduction, 16.5 cm Waist Circumference Decrease, SBP/DBP Reductions of 22.9/12.9 mmHg, 70.7 μmol/L Uric Acid Reduction, and 33.6% Triglyceride Reduction: BGM0504 Demonstrates Comprehensive Cardiometabolic Regulation Capabilities
SUZHOU, China, May 6, 2026 /PRNewswire/ -- Recently, BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as "BrightGene Bio-Medical " or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent insulinotropic polypeptide) dual receptor ...
2026-05-07 00:10
5106
ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities
BETHLEHEM, Pa., May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of itsProcess Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the biopr...
2026-05-06 22:09
3950
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 293 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 282 media titles]
2026-10-15 10:00SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 280 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
26132
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
15464